AcceSS and Equity in Transplantation (ASSET) New Zealand: Protocol for population-wide data linkage platform to investigate equity in access to kidney failure health services in New Zealand.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2022
2022
Historique:
received:
19
04
2022
accepted:
07
08
2022
entrez:
25
8
2022
pubmed:
26
8
2022
medline:
30
8
2022
Statut:
epublish
Résumé
Kidney transplantation is considered the ideal treatment for most people with kidney failure, conferring both survival and quality of life advantages, and is more cost effective than dialysis. Yet, current health systems may serve some people better than others, creating inequities in access to kidney failure treatments and health outcomes. AcceSS and Equity in Transplantation (ASSET) investigators aim to create a linked data platform to facilitate research enquiry into equity of health service delivery for people with kidney failure in New Zealand. The New Zealand Ministry of Health will use patients' National Health Index (NHI) numbers to deterministically link individual records held in existing registry and administrative health databases in New Zealand to create the data platform. The initial data linkage will include a study population of incident patients captured in the Australia and New Zealand Dialysis and Transplant Registry (ANZDATA), New Zealand Blood Service Database and the Australia and New Zealand Living Kidney Donor Registry (ANZLKD) from 2006 to 2019 and their linked health data. Health data sources will include National Non-Admitted Patient Collection Data, National Minimum Dataset, Cancer Registry, Programme for the Integration of Mental Health Data (PRIMHD), Pharmaceutical Claims Database and Mortality Collection Database. Initial exemplar studies include 1) kidney waitlist dynamics and pathway to transplantation; 2) impact of mental illness on accessing kidney waitlist and transplantation; 3) health service use of living donors following donation. The AcceSS and Equity in Transplantation (ASSET) linked data platform will provide opportunity for population-based health services research to examine equity in health care delivery and health outcomes in New Zealand. It also offers potential to inform future service planning by identifying where improvements can be made in the current health system to promote equity in access to health services for those in New Zealand.
Sections du résumé
BACKGROUND
Kidney transplantation is considered the ideal treatment for most people with kidney failure, conferring both survival and quality of life advantages, and is more cost effective than dialysis. Yet, current health systems may serve some people better than others, creating inequities in access to kidney failure treatments and health outcomes. AcceSS and Equity in Transplantation (ASSET) investigators aim to create a linked data platform to facilitate research enquiry into equity of health service delivery for people with kidney failure in New Zealand.
METHODS
The New Zealand Ministry of Health will use patients' National Health Index (NHI) numbers to deterministically link individual records held in existing registry and administrative health databases in New Zealand to create the data platform. The initial data linkage will include a study population of incident patients captured in the Australia and New Zealand Dialysis and Transplant Registry (ANZDATA), New Zealand Blood Service Database and the Australia and New Zealand Living Kidney Donor Registry (ANZLKD) from 2006 to 2019 and their linked health data. Health data sources will include National Non-Admitted Patient Collection Data, National Minimum Dataset, Cancer Registry, Programme for the Integration of Mental Health Data (PRIMHD), Pharmaceutical Claims Database and Mortality Collection Database. Initial exemplar studies include 1) kidney waitlist dynamics and pathway to transplantation; 2) impact of mental illness on accessing kidney waitlist and transplantation; 3) health service use of living donors following donation.
CONCLUSION
The AcceSS and Equity in Transplantation (ASSET) linked data platform will provide opportunity for population-based health services research to examine equity in health care delivery and health outcomes in New Zealand. It also offers potential to inform future service planning by identifying where improvements can be made in the current health system to promote equity in access to health services for those in New Zealand.
Identifiants
pubmed: 36006937
doi: 10.1371/journal.pone.0273371
pii: PONE-D-22-11414
pmc: PMC9409516
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0273371Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Am J Transplant. 2011 Oct;11(10):2093-109
pubmed: 21883901
PLoS One. 2021 Jan 15;16(1):e0245131
pubmed: 33449936
Pediatr Nephrol. 2016 Jun;31(6):1011-9
pubmed: 26692022
Am J Transplant. 2012 Feb;12(2):358-68
pubmed: 22233181
Transplantation. 2012 Aug 15;94(3):205-10
pubmed: 22430067
ANZ J Surg. 2021 Dec;91(12):2656-2662
pubmed: 34101327
J Am Soc Nephrol. 2009 Mar;20(3):621-8
pubmed: 19129311
Nephrology (Carlton). 2019 Jul;24(7):758-766
pubmed: 30159950
Front Med (Lausanne). 2022 Jan 24;8:800933
pubmed: 35141249
PLoS One. 2016 Jul 06;11(7):e0158765
pubmed: 27383068
Int J Equity Health. 2019 Dec 30;18(1):204
pubmed: 31888651
Clin J Am Soc Nephrol. 2021 Feb 8;16(2):241-250
pubmed: 33500250
Clin J Am Soc Nephrol. 2010 Dec;5(12):2338-47
pubmed: 20876682
Lancet Public Health. 2018 Jul;3(7):e323-e332
pubmed: 29908859
PLoS One. 2012;7(1):e29591
pubmed: 22279541
BMC Nephrol. 2020 Sep 23;21(1):411
pubmed: 32967630
Nephrology (Carlton). 2022 May;27(5):421-429
pubmed: 34985814
Lancet. 2020 Feb 29;395(10225):709-733
pubmed: 32061315
Kidney Int. 2009 Sep;76(6):659-64
pubmed: 19553910
Nephrol Dial Transplant. 2010 Aug;25(8):2624-32
pubmed: 20207710
J Racial Ethn Health Disparities. 2022 Jan 11;:
pubmed: 35018578
Med J Aust. 2019 Oct;211(8):374-380.e3
pubmed: 31595516
Kidney Int Rep. 2020 Dec 13;6(3):727-736
pubmed: 33732987